Cognizant Health Sciences — Goodwill increased by 0.7% to $2.92B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 0.7%, from $2.90B to $2.92B.
An increase suggests recent acquisition activity or a revaluation of assets, while a decrease may indicate impairment charges due to underperformance in the segment.
This metric represents the total carrying value of goodwill allocated to the Health Sciences business segment. It reflec...
Peers like Accenture or Infosys report similar goodwill balances based on their specific M&A strategies within the healthcare consulting vertical.
ctsh_segment_health_sciences_goodwill| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $2.83B | $2.82B | $2.84B | $2.90B | $2.92B |
| QoQ Change | — | -0.4% | +0.7% | +1.9% | +0.7% |
| YoY Change | — | -0.4% | +0.7% | +1.9% | +0.7% |